Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,218,842,409
+$112,854,564 QoQ
Shares Held
4,799,159
+6.1% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
2.25%
of 13F equity value
Holder Rank
#59
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. JNJ ranks #1 (48.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
|
134,149 | $25,437,332 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,218,842,409 | 4,799,159 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,105,987,845 | 4,524,578 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $904,408,749 | 4,370,180 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $792,997,950 | 4,276,766 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $635,682,566 | 4,161,588 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $679,020,270 | 4,094,430 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $568,403,455 | 3,930,324 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $665,068,471 | 4,103,841 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $589,844,318 | 4,035,607 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $633,847,555 | 4,006,875 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $615,455,596 | 3,926,602 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $594,260,540 | 3,815,477 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $632,705,824 | 3,822,534 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $740,483,515 | 4,777,313 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $820,468,587 | 4,644,600 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $686,911,155 | 4,204,892 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $726,365,061 | 4,091,967 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $698,189,785 | 3,939,456 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $634,970,952 | 3,711,761 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $540,144,178 | 3,344,546 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $540,809,460 | 3,282,806 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $552,700,502 | 3,362,948 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $514,536,597 | 3,269,390 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $474,747,501 | 3,188,793 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $443,767,949 | 3,155,571 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $398,014,954 | 3,035,270 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||